Eledon Pharmaceuticals, Inc. (ELDN) › Shareholders' EquityEledon Pharmaceuticals, Inc. (ELDN) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2011: -$30.43M2012: -$39.90M2013: -$55.27M2014: $103.50M2015: $2.78M2016: -$2.70M2017: $19.45M2018: $14.49M2019: $9.46M2020: $190.60M2021: $164.00M2022: $23.79M2023: -$48.49M2024: $62.45M2025: $81.08M$81.08M2011Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$81.08M+29.8%2024$62.45M+228.8%2023-$48.49M-303.8%2022$23.79M-85.5%2021$164.00M-14.0%2020$190.60M+1913.7%2019$9.46M-34.7%2018$14.49M-25.5%2017$19.45M+819.9%2016-$2.70M-197.1%2015$2.78M-97.3%2014$103.50M+287.3%2013-$55.27M-38.5%2012-$39.90M-31.1%2011-$30.43M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share